2022年7月14日 智權新聞彙整

• 2022京臺智慧財產權論壇 (線上活動)

-

-

-

• 沒交專利費日本行銷付之流水 中國醫判賠生技公司200萬 (聯合新聞網)
• 【公告】漢達治療癌症505(b)(2)新藥HND-027取得台灣專利 (Yahoo新聞)
• 【公告】欣耀脂肪肝炎新藥SNP-630取得中華民國專利 (Yahoo股市 新聞發布)
• 醣聯抗癌新藥GNX102 獲得美國專利 (聯合新聞網)

• 蘋果新專利曝光！　AirPods Pro自動偵測、調音量「避免用戶出車禍」 (ETtoday新聞雲)

• TOYOTA超炫「越野影像輔助」專利曝光　整個內裝都能透視路況！ (ETtoday新聞雲)

• 蘋果在這國iPad、iPhone不能賣了　只因違反這件事 (ETtoday新聞雲)
• Panasonic提訴訟 控告博通侵害專利 (鉅亨網)
• Nokia打贏5G專利訴訟！OPPO禁止在德國販售 (新頭殼新聞)

-

• 現代汽車公司提交NFT相關商標申請 (鉅亨網)
• 「冰淇淋刺客」 「冰淇淋護衛」被搶注商標 (新浪新聞)
• 美國寵物連鎖店PETCO提交相關NFT商標申請 (鉅亨網)

• パナソニックＨＤ、米ブロードコムを提訴　特許侵害で
• 窪田製薬ホールディングス—米国で遠隔眼科医療用網膜モニタリング機器「PBOS」に関する特許を取得
• ラクオリア創薬—大幅に6日続伸、がん幹細胞の増殖抑制剤の用途特許が欧州で特許査定
• iPhoneとiPadの5Gモデル販売禁止〜コロンビアで、5G関連特許を巡る裁判

• InDex Pharmaceuticals gets new patent for cobitolimod granted in Europe
• Indonesian court dismisses all four patent infringement complaints by Nokia against OPPO and affiliates, imposes costs on Nokia
• German Court Rules that Gilead’s Sofosbuvir Infringes NuCana’s ‘190 Patent
• Nokia Wins 4G/5G Patent Case, Oppo And OnePlus Banned In Germany
• Lightbridge Receives Notice of Allowance on Key Patent from the Canadian Intellectual Property Office

• Apple says Ericsson filed ‘secret’ Colombian patent lawsuits to sideline Texas court
• Catalyst Pharmaceuticals Announces Settlement of U.S. Patent Litigation and Resolution of Litigation Challenging Ruzurgi® Approval with Jacobus Pharmaceutical
• Pfizer, Moderna COVID-19 vaccines infringe new Alnylam patent, lawsuits say
• Trust Stamp Receives Notice of Allowance for U.S Patent Related to its Biometric Authentication Technology
• PharmaTher Announces Notice of Allowance for U.S. Patent Covering Ketamine for the Potential Treatment of Parkinson’s Disease and Motor Disorders
• Chemours settles polymer patent dispute with Daikin just before trial